Arterial lactate vs venous lactate as indicator of metabolic limitation during cardiopulmonary exercise testing.

M. Habes (Amsterdam, Netherlands), R. Salvador (Amsterdam, Netherlands), E. Dijkers (Amsterdam, Netherlands), R. Van Steenwijk (Amsterdam, Netherlands)

Source: International Congress 2018 – Respiratory physiology and measurements
Session: Respiratory physiology and measurements
Session type: Thematic Poster
Number: 1408
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Habes (Amsterdam, Netherlands), R. Salvador (Amsterdam, Netherlands), E. Dijkers (Amsterdam, Netherlands), R. Van Steenwijk (Amsterdam, Netherlands). Arterial lactate vs venous lactate as indicator of metabolic limitation during cardiopulmonary exercise testing.. 1408

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009


Predictive value of combined metabolic and cardiopulmonary responses to estimate maximal aerobic impairment in patients with pulmonary arterial hypertension
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010

The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Year: 2018



Maximal cardiopulmonary exercise testing in children with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


The measurement of arterial blood gas lactate levels as a marker of tissue hypoxia in OSAS and overlap syndrome
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Relationship of pulmonary arterial pressure at high altitude with oxygen saturation and exercise test
Source: International Congress 2015 – Pathophysiological mechanisms at different scales: lung, airways, muscles and symptom perception
Year: 2015

Diagnostic accuracy of venous blood gases compared to arterial blood gases
Source: Annual Congress 2013 –Various issues in clinical respiratory physiology
Year: 2013


Prognostic value of end-tidal partial pressure of carbon dioxide during cardiopulmonary exercise test in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Arterialised-venous blood as a surrogate measure of arterial pH and CO2 in patients with hypercapnic respiratory failure
Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control
Year: 2010

Pilot study to assess physician compliance in non-invasive ventilation titration based on venous blood gasses versus arterial blood gasses in acute respiratory failure patients
Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care
Year: 2020




Arterial lactate levels in cases of COPD with respiratory failure
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Relationship between pulse transit time and blood pressure during cardiopulmonary exercise tests
Source: Annual Congress 2011 - Innovative methods in exercise testing
Year: 2011


Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Gas exchange abnormality during cardiopulmonary exercise test in patients with primary pulmonary hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012

Lower arterial oxygen partial pressure and saturation during treadmill compared to cycle exercise in COPD
Source: Annual Congress 2010 - Gas exchange and paediatric exercise testing
Year: 2010

Relationship between blood potassium, hydrogen, lactate ions and pulmonary ventilation during different exercise testing protocols
Source: Eur Respir J 2002; 20: Suppl. 38, 297s
Year: 2002

Upper extremity aerobic exercise training improves peak oxygen consumption in patients with pulmonary arterial hypertension
Source: International Congress 2018 – Chronic lung disease : effects of rehabilitation interventions on functional outcomes in patients
Year: 2018


Is continuous laryngoscopy during cardiopulmonary exercise testing reliable for measuring maximum oxygen uptake?
Source: International Congress 2018 – Exercise is medicine: testing and treating patients with some effort
Year: 2018